Author | Peter Young

Articles

Pharma & Biotech: Financial Pulse-Check, Outlook

Pharmaceutical Executive

Article

A review of market performance and trends in 2018 and first quarter of 2019 for the life sciences industry.

CFIUS Reform’s Impact on Biopharma

Pharmaceutical Executive

Article

What the new rules mean for Chinese-related investments and acquisitions in the US.

Biopharma Business Check

Pharmaceutical Executive

Article

The increase in new drug approvals and candidates in development are good signs for pharma and biotech, but both sectors face continued pricing, cost, and healthcare policy-related challenges ahead.

China’s Biopharma Rise: Opportunities and Threats

Pharmaceutical Executive

Article

Exploring the prospects-and related challenges-for Chinese life science as it aggressively pursues new growth areas.